REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)
CUSIP: 76152G100
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 12,805,677
- Total 13F shares
- 6,849,687
- Share change
- +1,278,893
- Total reported value
- $8,748,871
- Put/Call ratio
- 30%
- Price per share
- $1.28
- Number of holders
- 30
- Value change
- +$1,342,404
- Number of buys
- 20
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 76152G100?
CUSIP 76152G100 identifies RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76152G100:
Top shareholders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Woodline Partners LP |
13F
|
Company |
8.2%
|
1,055,009
|
$3,987,934 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.8%
|
1,001,836
|
$3,786,940 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
6.7%
|
854,597
|
$3,230,377 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
6.5%
|
826,600
|
$3,124,548 | — | 31 Mar 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
3.9%
|
503,854
|
$1,904,568 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.9%
|
242,667
|
$917,281 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
220,117
|
$832,219 | — | 31 Mar 2024 | |
| Focus Partners Wealth |
13F
|
Company |
1.3%
|
171,000
|
$646,000 | — | 31 Mar 2024 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
1.2%
|
154,800
|
$585,144 | — | 31 Mar 2024 | |
| EMC Capital Management |
13F
|
Company |
0.97%
|
123,915
|
$411,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.72%
|
91,861
|
$347,234 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.49%
|
63,200
|
$238,896 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.39%
|
50,448
|
$190,693 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.3%
|
38,663
|
$146,146 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.27%
|
34,868
|
$131,801 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.23%
|
30,090
|
$113,740 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.17%
|
21,929
|
$82,892 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.17%
|
21,513
|
$81,319 | — | 31 Mar 2024 | |
| Vontobel Holding Ltd. |
13F
|
Company |
0.11%
|
14,000
|
$52,920 | — | 31 Mar 2024 | |
| NRI Wealth Management LC |
13F
|
Company |
0.1%
|
12,380
|
$46,796 | — | 31 Mar 2024 | |
| BluePointe Capital Management, LLC |
13F
|
Company |
0.08%
|
10,378
|
$39,229 | — | 31 Mar 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.07%
|
9,299
|
$35,150 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
8,099
|
$30,614 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
5,621
|
$21,247 | — | 31 Mar 2024 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.03%
|
3,375
|
$12,757 | — | 31 Mar 2024 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.02%
|
3,043
|
$11,000 | — | 31 Mar 2024 | |
| Archer Investment Corp |
13F
|
Company |
0%
|
500
|
$1,890 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
175
|
$662 | — | 31 Mar 2024 | |
| VEDANTA PARTNERS, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
1,127,207
mixed-class rows
|
— | — | 08 Sep 2022 |
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q2 2024
As of 30 Jun 2024,
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,849,687 shares.
The largest 10 holders included
Woodline Partners LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, Parkman Healthcare Partners LLC, SABBY MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, Colony Group, LLC, Polar Asset Management Partners Inc., and UBS Group AG.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
28
Q2 2024 holders
30
Holder diff
2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.